Tsui Chung Ki
DEPT
Department of Medicine
FACULTY
Li Ka Shing Faculty of Medicine
COVID-19 Contribution
Showing 1 - 1 out of 1
Show
20
Relevance
23 Feb 2023
While molnupiravir (MOV) and nirmatrelvir–ritonavir (NMV-r) were developed for treatment of mild to moderate COVID-19 infection, there has been a lack...Read more